Dr. Kelle H. Moley, MD is Vice President of Women’s Health and Early Clinical Development at Eli Lilly and Company, where she leads early clinical strategy to advance new therapies in women’s health. She is a distinguished physician-scientist with more than three decades of experience spanning academic medicine, nonprofit leadership, global health strategy, industry drug development, and translational research in women’s reproductive biology.

Most recently, Dr. Moley served as Global Vice President of Clinical and Translational R&D, Reproductive Medicine and Maternal Health at Ferring Pharmaceuticals. Before Ferring, she served as Deputy Director of Reproductive Health Technologies at the Bill & Melinda Gates Foundation and as Chief Scientific Officer at March of Dimes, shaping strategic platforms to address sexual and reproductive health equity globally.

Dr. Moley’s career began in academic medicine, where she spent nearly 30 years at Washington University in St. Louis School of Medicine, rising to become James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, and Director of the Center for Reproductive Health Sciences. Her research on reproductive physiology and metabolic influences on development earned international recognition, including election to the National Academy of Medicine.

Education: BA, Wellesley College; MD, Yale School of Medicine.